LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Sahoo, Anusmita"
  2. AU="Ohnishi, Toshiyuki"
  3. AU="Engelhardt, John F"
  4. AU="Pike, J Wesley"
  5. AU="Heijdra Suasnabar, Jan M"
  6. AU="Galanaud, Damien"
  7. AU="Edmison, Anna"
  8. AU="Hall, Charles B"

Suchergebnis

Treffer 1 - 10 von insgesamt 13

Suchoptionen

  1. Artikel ; Online: Protein model discrimination attempts using mutational sensitivity, predicted secondary structure, and model quality information.

    Khare, Shruti / Bhasin, Munmun / Sahoo, Anusmita / Varadarajan, Raghavan

    Proteins

    2019  Band 87, Heft 4, Seite(n) 326–336

    Abstract: Structure prediction methods often generate a large number of models for a target sequence. Even if the correct fold for the target sequence is sampled in this dataset, it is difficult to distinguish it from other decoy structures. An attempt to solve ... ...

    Abstract Structure prediction methods often generate a large number of models for a target sequence. Even if the correct fold for the target sequence is sampled in this dataset, it is difficult to distinguish it from other decoy structures. An attempt to solve this problem using experimental mutational sensitivity data for the CcdB protein was described previously by exploiting the correlation of residue depth with mutational sensitivity (r ~ 0.6). We now show that such a correlation extends to four other proteins with localized active sites, and for which saturation mutagenesis datasets exist. We also examine whether incorporation of predicted secondary structure information and the DOPE model quality assessment score, in addition to mutational sensitivity, improves the accuracy of model discrimination using a decoy dataset of 163 targets from CASP. Although most CASP models would have been subjected to model quality assessment prior to submission, we find that the DOPE score makes a substantial contribution to the observed improvement. We therefore also applied the approach to CcdB and four other proteins for which reliable experimental mutational data exist and observe that inclusion of experimental mutational data results in a small qualitative improvement in model discrimination relative to that seen with just the DOPE score. This is largely because of our limited ability to quantitatively predict effects of point mutations on in vivo protein activity. Further improvements in the methodology are required to facilitate improved utilization of single mutant data.
    Mesh-Begriff(e) Animals ; Catalytic Domain ; Databases, Protein ; Humans ; Models, Biological ; Models, Molecular ; Mutagenesis ; Mutation ; Protein Folding ; Protein Structure, Secondary ; Proteins/chemistry ; Proteins/genetics
    Chemische Substanzen Proteins
    Sprache Englisch
    Erscheinungsdatum 2019-01-15
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 806683-8
    ISSN 1097-0134 ; 0887-3585
    ISSN (online) 1097-0134
    ISSN 0887-3585
    DOI 10.1002/prot.25654
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: A microbiota and dietary metabolite integrates DNA repair and cell death to regulate embryo viability and aneuploidy during aging.

    Sonowal, Robert / Swimm, Alyson I / Cingolani, Francesca / Parulekar, Noyonika / Cleverley, Tesia L / Sahoo, Anusmita / Ranawade, Ayush / Chaudhuri, Debalina / Mocarski, Edward S / Koehler, Heather / Nitsche, Karolina / Mesiano, Sam / Kalman, Daniel

    Science advances

    2023  Band 9, Heft 8, Seite(n) eade8653

    Abstract: During aging, environmental stressors and mutations along with reduced DNA repair cause germ cell aneuploidy and genome instability, which limits fertility and embryo development. Benevolent commensal microbiota and dietary plants secrete indoles, which ... ...

    Abstract During aging, environmental stressors and mutations along with reduced DNA repair cause germ cell aneuploidy and genome instability, which limits fertility and embryo development. Benevolent commensal microbiota and dietary plants secrete indoles, which improve healthspan and reproductive success, suggesting regulation of germ cell quality. We show that indoles prevent aneuploidy and promote DNA repair and embryo viability, which depends on age and genotoxic stress levels and affects embryo quality across generations. In young animals or with low doses of radiation, indoles promote DNA repair and embryo viability; however, in older animals or with high doses of radiation, indoles promote death of the embryo. These studies reveal a previously unknown quality control mechanism by which indole integrates DNA repair and cell death responses to preclude germ cell aneuploidy and ensure transgenerational genome integrity. Such regulation affects healthy aging, reproductive senescence, cancer, and the evolution of genetic diversity in invertebrates and vertebrates.
    Mesh-Begriff(e) Animals ; Aneuploidy ; DNA Repair ; Cell Death ; Indoles ; Microbiota
    Chemische Substanzen Indoles
    Sprache Englisch
    Erscheinungsdatum 2023-02-24
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.ade8653
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.

    Styles, Tiffany M / Gangadhara, Sailaja / Reddy, Pradeep B J / Sahoo, Anusmita / Shiferaw, Ayalensh / Welbourn, Sarah / Kozlowski, Pamela A / Derdeyn, Cynthia A / Velu, Vijayakumar / Amara, Rama Rao

    Frontiers in immunology

    2022  Band 13, Seite(n) 914969

    Abstract: Stabilized HIV envelope (Env) trimeric protein immunogens have been shown to induce strong autologous neutralizing antibody response. However, there is limited data on the immunogenicity and efficacy of stabilized Env expressed by a viral vector-based ... ...

    Abstract Stabilized HIV envelope (Env) trimeric protein immunogens have been shown to induce strong autologous neutralizing antibody response. However, there is limited data on the immunogenicity and efficacy of stabilized Env expressed by a viral vector-based immunogen. Here, we compared the immunogenicity and efficacy of two modified vaccinia Ankara (MVA) vaccines based on variable loop 2 hotspot (V2 HS) optimized C.1086 envelope (Env) sequences, one expressing the membrane anchored gp150 (MVA-150) and the other expressing soluble uncleaved pre-fusion optimized (UFO) gp140 trimer (MVA-UFO) in a DNA prime/MVA boost approach against heterologous tier 2 SHIV1157ipd3N4 intrarectal challenges in rhesus macaques (RMs). Both MVA vaccines also expressed SIVmac239 Gag and form virus-like particles. The DNA vaccine expressed SIVmac239 Gag, C.1086 gp160 Env and rhesus CD40L as a built-in adjuvant. Additionally, all immunizations were administered intradermally (ID) to reduce induction of vaccine-specific IFNγ+ CD4 T cell responses. Our results showed that both MVA-150 and MVA-UFO vaccines induce comparable Env specific IgG responses in serum and rectal secretions. The vaccine-induced serum antibody showed ADCC and ADCVI activities against the challenge virus. Comparison with a previous study that used similar immunogens
    Mesh-Begriff(e) Animals ; Antibodies, Viral ; DNA ; HIV-1/genetics ; Macaca mulatta ; Vaccines, DNA ; Vaccinia ; Vaccinia virus/genetics ; Viral Vaccines
    Chemische Substanzen Antibodies, Viral ; MVA vaccine ; Vaccines, DNA ; Viral Vaccines ; DNA (9007-49-2)
    Sprache Englisch
    Erscheinungsdatum 2022-07-22
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2022.914969
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies.

    Sahoo, Anusmita / Hodge, Edgar A / LaBranche, Celia C / Styles, Tiffany M / Shen, Xiaoying / Cheedarla, Narayanaiah / Shiferaw, Ayalnesh / Ozorowski, Gabriel / Lee, Wen-Hsin / Ward, Andrew B / Tomaras, Georgia D / Montefiori, David C / Irvine, Darrell J / Lee, Kelly K / Amara, Rama Rao

    Cell reports

    2022  Band 38, Heft 9, Seite(n) 110436

    Abstract: HIV-1 clade C envelope immunogens that elicit both neutralizing and non-neutralizing V1V2-scaffold-specific antibodies (protective correlates from RV144 human trial) are urgently needed due to the prevalence of this clade in the most impacted regions ... ...

    Abstract HIV-1 clade C envelope immunogens that elicit both neutralizing and non-neutralizing V1V2-scaffold-specific antibodies (protective correlates from RV144 human trial) are urgently needed due to the prevalence of this clade in the most impacted regions worldwide. To achieve this, we introduce structure-guided changes followed by consensus-C-sequence-guided optimizations at the V2 region to generate UFO-v2-RQH
    Mesh-Begriff(e) AIDS Vaccines ; Animals ; Antibodies, Neutralizing ; HIV Antibodies ; HIV Antigens ; HIV Infections ; HIV Seropositivity ; HIV-1 ; Rabbits ; env Gene Products, Human Immunodeficiency Virus
    Chemische Substanzen AIDS Vaccines ; Antibodies, Neutralizing ; HIV Antibodies ; HIV Antigens ; env Gene Products, Human Immunodeficiency Virus
    Sprache Englisch
    Erscheinungsdatum 2022-03-02
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2022.110436
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.

    Sahoo, Anusmita / Jones, Andrew T / Cheedarla, Narayanaiah / Gangadhara, Sailaja / Roy, Vicky / Styles, Tiffany M / Shiferaw, Ayalnesh / Walter, Korey L / Williams, LaTonya D / Shen, Xiaoying / Ozorowski, Gabriel / Lee, Wen-Hsin / Burton, Samantha / Yi, Lasanajak / Song, Xuezheng / Qin, Zhaohui S / Derdeyn, Cynthia A / Ward, Andrew B / Clements, John D /
    Varadarajan, Raghavan / Tomaras, Georgia D / Kozlowski, Pamela A / Alter, Galit / Amara, Rama Rao

    Science immunology

    2022  Band 7, Heft 73, Seite(n) eabl4102

    Abstract: The rising global HIV-1 burden urgently requires vaccines capable of providing heterologous protection. Here, we developed a clade C HIV-1 vaccine consisting of priming with modified vaccinia Ankara (MVA) and boosting with cyclically permuted trimeric ... ...

    Abstract The rising global HIV-1 burden urgently requires vaccines capable of providing heterologous protection. Here, we developed a clade C HIV-1 vaccine consisting of priming with modified vaccinia Ankara (MVA) and boosting with cyclically permuted trimeric gp120 (CycP-gp120) protein, delivered either orally using a needle-free injector or through parenteral injection. We tested protective efficacy of the vaccine against intrarectal challenges with a pathogenic heterologous clade C SHIV infection in rhesus macaques. Both routes of vaccination induced a strong envelope-specific IgG in serum and rectal secretions directed against V1V2 scaffolds from a global panel of viruses with polyfunctional activities. Envelope-specific IgG showed lower fucosylation compared with total IgG at baseline, and most of the vaccine-induced proliferating blood CD4
    Mesh-Begriff(e) AIDS Vaccines ; Animals ; CD8-Positive T-Lymphocytes ; Glycosylation ; HIV-1 ; Immunoglobulin G ; Macaca mulatta ; Simian Immunodeficiency Virus ; T-Lymphocytes, Helper-Inducer ; Tumor Necrosis Factor-alpha ; Vaccinia virus
    Chemische Substanzen AIDS Vaccines ; Immunoglobulin G ; Tumor Necrosis Factor-alpha
    Sprache Englisch
    Erscheinungsdatum 2022-07-22
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2470-9468
    ISSN (online) 2470-9468
    DOI 10.1126/sciimmunol.abl4102
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online ; Forschungsdaten: (mit Forschungsdaten) Residue proximity information and protein model discrimination using saturation-suppressor mutagenesis.

    Sahoo, Anusmita / Khare, Shruti / Devanarayanan, Sivasankar / Jain, Pankaj C / Varadarajan, Raghavan

    eLife

    2015  Band 4

    Abstract: Identification of residue-residue contacts from primary sequence can be used to guide protein structure prediction. Using Escherichia coli CcdB as the test case, we describe an experimental method termed saturation-suppressor mutagenesis to acquire ... ...

    Abstract Identification of residue-residue contacts from primary sequence can be used to guide protein structure prediction. Using Escherichia coli CcdB as the test case, we describe an experimental method termed saturation-suppressor mutagenesis to acquire residue contact information. In this methodology, for each of five inactive CcdB mutants, exhaustive screens for suppressors were performed. Proximal suppressors were accurately discriminated from distal suppressors based on their phenotypes when present as single mutants. Experimentally identified putative proximal pairs formed spatial constraints to recover >98% of native-like models of CcdB from a decoy dataset. Suppressor methodology was also applied to the integral membrane protein, diacylglycerol kinase A where the structures determined by X-ray crystallography and NMR were significantly different. Suppressor as well as sequence co-variation data clearly point to the X-ray structure being the functional one adopted in vivo. The methodology is applicable to any macromolecular system for which a convenient phenotypic assay exists.
    Mesh-Begriff(e) Bacterial Proteins/chemistry ; Bacterial Proteins/genetics ; Diacylglycerol Kinase/chemistry ; Diacylglycerol Kinase/genetics ; Escherichia coli/chemistry ; Escherichia coli/enzymology ; Escherichia coli/genetics ; Models, Molecular ; Mutagenesis ; Protein Conformation ; Suppression, Genetic
    Chemische Substanzen Bacterial Proteins ; CcdB protein, Plasmid F ; Diacylglycerol Kinase (EC 2.7.1.107)
    Sprache Englisch
    Erscheinungsdatum 2015-12-30
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.09532
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.

    Bollimpelli, Venkata S / Reddy, Pradeep B J / Gangadhara, Sailaja / Charles, Tysheena P / Burton, Samantha L / Tharp, Gregory K / Styles, Tiffany M / Labranche, Celia C / Smith, Justin C / Upadhyay, Amit A / Sahoo, Anusmita / Legere, Traci / Shiferaw, Ayalnesh / Velu, Vijayakumar / Yu, Tianwei / Tomai, Mark / Vasilakos, John / Kasturi, Sudhir P / Shaw, George M /
    Montefiori, David / Bosinger, Steven E / Kozlowski, Pamela A / Pulendran, Bali / Derdeyn, Cynthia A / Hunter, Eric / Amara, Rama R

    Nature communications

    2023  Band 14, Heft 1, Seite(n) 4789

    Abstract: Route of immunization can markedly influence the quality of immune response. Here, we show that intradermal (ID) but not intramuscular (IM) modified vaccinia Ankara (MVA) vaccinations provide protection from acquisition of intravaginal tier2 simian-human ...

    Abstract Route of immunization can markedly influence the quality of immune response. Here, we show that intradermal (ID) but not intramuscular (IM) modified vaccinia Ankara (MVA) vaccinations provide protection from acquisition of intravaginal tier2 simian-human immunodeficiency virus (SHIV) challenges in female macaques. Both routes of vaccination induce comparable levels of serum IgG with neutralizing and non-neutralizing activities. The protection in MVA-ID group correlates positively with serum neutralizing and antibody-dependent phagocytic activities, and envelope-specific vaginal IgA; while the limited protection in MVA-IM group correlates only with serum neutralizing activity. MVA-ID immunizations induce greater germinal center Tfh and B cell responses, reduced the ratio of Th1 to Tfh cells in blood and showed lower activation of intermediate monocytes and inflammasome compared to MVA-IM immunizations. This lower innate activation correlates negatively with induction of Tfh responses. These data demonstrate that the MVA-ID vaccinations protect against intravaginal SHIV challenges by modulating the innate and T helper responses.
    Mesh-Begriff(e) Animals ; Humans ; Female ; Simian Acquired Immunodeficiency Syndrome/prevention & control ; Vaccinia/prevention & control ; Macaca mulatta ; Simian Immunodeficiency Virus ; Vaccinia virus ; Vaccination ; HIV ; Antibodies, Viral
    Chemische Substanzen Antibodies, Viral
    Sprache Englisch
    Erscheinungsdatum 2023-08-08
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-40430-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.

    Routhu, Nanda Kishore / Cheedarla, Narayanaiah / Bollimpelli, Venkata Satish / Gangadhara, Sailaja / Edara, Venkata Viswanadh / Lai, Lilin / Sahoo, Anusmita / Shiferaw, Ayalnesh / Styles, Tiffany M / Floyd, Katharine / Fischinger, Stephanie / Atyeo, Caroline / Shin, Sally A / Gumber, Sanjeev / Kirejczyk, Shannon / Dinnon, Kenneth H / Shi, Pei-Yong / Menachery, Vineet D / Tomai, Mark /
    Fox, Christopher B / Alter, Galit / Vanderford, Thomas H / Gralinski, Lisa / Suthar, Mehul S / Amara, Rama Rao

    Nature communications

    2021  Band 12, Heft 1, Seite(n) 3587

    Abstract: There is a great need for the development of vaccines that induce potent and long-lasting protective immunity against SARS-CoV-2. Multimeric display of the antigen combined with potent adjuvant can enhance the potency and longevity of the antibody ... ...

    Abstract There is a great need for the development of vaccines that induce potent and long-lasting protective immunity against SARS-CoV-2. Multimeric display of the antigen combined with potent adjuvant can enhance the potency and longevity of the antibody response. The receptor binding domain (RBD) of the spike protein is a primary target of neutralizing antibodies. Here, we developed a trimeric form of the RBD and show that it induces a potent neutralizing antibody response against live virus with diverse effector functions and provides protection against SARS-CoV-2 challenge in mice and rhesus macaques. The trimeric form induces higher neutralizing antibody titer compared to monomer with as low as 1μg antigen dose. In mice, adjuvanting the protein with a TLR7/8 agonist formulation alum-3M-052 induces 100-fold higher neutralizing antibody titer and superior protection from infection compared to alum. SARS-CoV-2 infection causes significant loss of innate cells and pathology in the lung, and vaccination protects from changes in innate cells and lung pathology. These results demonstrate RBD trimer protein as a suitable candidate for vaccine against SARS-CoV-2.
    Mesh-Begriff(e) Adjuvants, Immunologic/administration & dosage ; Alum Compounds/administration & dosage ; Angiotensin-Converting Enzyme 2/immunology ; Angiotensin-Converting Enzyme 2/metabolism ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Antibody Formation/immunology ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Disease Models, Animal ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Heterocyclic Compounds, 3-Ring/immunology ; Humans ; Macaca mulatta ; Mice ; Protein Binding ; SARS-CoV-2/isolation & purification ; Spike Glycoprotein, Coronavirus/immunology ; Stearic Acids/administration & dosage ; Stearic Acids/immunology
    Chemische Substanzen Adjuvants, Immunologic ; Alum Compounds ; Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Heterocyclic Compounds, 3-Ring ; Spike Glycoprotein, Coronavirus ; Stearic Acids ; spike protein, SARS-CoV-2 ; MEDI9197 (16598XQ2BT) ; aluminum sulfate (34S289N54E) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Sprache Englisch
    Erscheinungsdatum 2021-06-11
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-23942-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response

    Routhu, Nanda Kishore / Gangadhara, Sailaja / Cheedarla, Narayanaiah / Shiferaw, Ayalnesh / Rahman, Sheikh Abdul / Sahoo, Anusmita / Shi, Pei-Yong / Menachery, Vineet D / Floyd, Katharine / Fischinger, Stephanie / Atyeo, Caroline / Alter, Galit / Suthar, Mehul S / Amara, Rama Rao

    bioRxiv

    Abstract: There is a great need for the development of vaccines for preventing SARS-CoV-2 infection and mitigating the COVID-19 pandemic. Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length ... ...

    Abstract There is a great need for the development of vaccines for preventing SARS-CoV-2 infection and mitigating the COVID-19 pandemic. Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length spike protein (MVA/S) stabilized in a prefusion state or the S1 region of the spike (MVA/S1) which forms trimers and is secreted. Both immunogens contained the receptor-binding domain (RBD) which is a known target of antibody-mediated neutralization. Following immunizations with MVA/S or MVA/S1, both spike protein recombinants induced strong IgG antibodies to purified full-length SARS-CoV-2 spike protein. The MVA/S induced a robust antibody response to purified RBD, S1 and S2 whereas MVA/S1 induced an antibody response to the S1 region outside of the RBD region. Both vaccines induced an antibody response in the lung and that was associated with induction of bronchus-associated lymphoid tissue. MVA/S but not MVA/S1 vaccinated mice generated robust neutralizing antibody responses against SARS-CoV-2 that strongly correlated with RBD antibody binding titers. Mechanistically, S1 binding to ACE-2 was strong but reduced following prolonged pre-incubation at room temperature suggesting confirmation changes in RBD with time. These results demonstrate MVA/S is a potential vaccine candidate against SARS-CoV-2 infection.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-06-27
    Verlag Cold Spring Harbor Laboratory
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2020.06.27.175166
    Datenquelle COVID19

    Kategorien

  10. Artikel ; Online: Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response

    Routhu, Nanda Kishore / Gangadhara, Sailaja / Cheedarla, Narayanaiah / Shiferaw, Ayalnesh / Rahman, Sheikh Abdul / Sahoo, Anusmita / Shi, Pei-Yong / Menachery, Vineet D. / Floyd, Katharine / Fischinger, Stephanie / Atyeo, Caroline / Alter, Galit / Suthar, Mehul S. / Amara, Rama Rao

    bioRxiv

    Abstract: There is a great need for the development of vaccines for preventing SARS-CoV-2 infection and mitigating the COVID-19 pandemic. Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length ... ...

    Abstract There is a great need for the development of vaccines for preventing SARS-CoV-2 infection and mitigating the COVID-19 pandemic. Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length spike protein (MVA/S) stabilized in a prefusion state or the S1 region of the spike (MVA/S1) which forms trimers and is secreted. Both immunogens contained the receptor-binding domain (RBD) which is a known target of antibody-mediated neutralization. Following immunizations with MVA/S or MVA/S1, both spike protein recombinants induced strong IgG antibodies to purified full-length SARS-CoV-2 spike protein. The MVA/S induced a robust antibody response to purified RBD, S1 and S2 whereas MVA/S1 induced an antibody response to the S1 region outside of the RBD region. Both vaccines induced an antibody response in the lung and that was associated with induction of bronchus-associated lymphoid tissue. MVA/S but not MVA/S1 vaccinated mice generated robust neutralizing antibody responses against SARS-CoV-2 that strongly correlated with RBD antibody binding titers. Mechanistically, S1 binding to ACE-2 was strong but reduced following prolonged pre-incubation at room temperature suggesting confirmation changes in RBD with time. These results demonstrate MVA/S is a potential vaccine candidate against SARS-CoV-2 infection.
    Schlagwörter covid19
    Verlag BioRxiv; WHO
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2020.06.27.175166
    Datenquelle COVID19

    Kategorien

Zum Seitenanfang